400-0512-686
Technical Support

Lumigenex(Suzhou) Co. Ltd., established in February 2010, is committed to R&D, production and sales of POCT(point of care testing) product(reagents and instrument) and biochemical diagnosis reagents, which is based on functionalized nanoparticles technology of IVD(in vitro diagnosis) industry.
 For your convenience, our company provide various technical service listed as follow: pre-sale consultation, after-sale service, openration checking consultation, troubleshooting technology forum.

Earlier
April 2014

Lumigenex receives CFDA approval for four POCT immunoassay kits to help physicians quickly and accurately diagnose heart diseases.

March 2014

Lumigenex receives CFDA approval for five immunoassay reagents adaptable to most chemical analyzers.

February 2014

Lumigenex received CFDA approval for time-resolved fluorescence immunochromatographic analyzer.

January 2014

Dr. He Aimin was named "National Thousand Talents Program"

December 2013

Lumigenex access to "high-tech enterprises in Jiangsu Province" title.

September 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment.